ORCID

Abstract

Large scale genetic studies such as genome-wide association studies (GWAS) in Parkinson's disease (PD) have revealed genetic susceptibility factors and continue to offer new insights both into the genetics of sporadic disease and its pathogenesis, with the potential for identification of an at-risk population and novel therapeutic targets. However, the methodology importantly requires larger data sets for replication of novel findings.

Publication Date

2013-01-01

Publication Title

Journal of Neurology, Neurosurgery and Psychiatry

Volume

84

Issue

11

ISSN

0022-3050

Keywords

PARKINSON'S DISEASE, STROKE

Share

COinS